- Home
- CCTG vs CASI Comparison
CCTG vs CASI Comparison
Compare CCTG & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTG
- CASI
- Stock Information
- Founded
- CCTG 1993
- CASI 1991
- Country
- CCTG Hong Kong
- CASI China
- Employees
- CCTG N/A
- CASI N/A
- Industry
- CCTG
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- CCTG
- CASI Health Care
- Exchange
- CCTG Nasdaq
- CASI Nasdaq
- Market Cap
- CCTG 25.7M
- CASI 24.9M
- IPO Year
- CCTG 2024
- CASI 1996
- Fundamental
- Price
- CCTG $0.22
- CASI $1.24
- Analyst Decision
- CCTG
- CASI Strong Buy
- Analyst Count
- CCTG 0
- CASI 1
- Target Price
- CCTG N/A
- CASI $4.00
- AVG Volume (30 Days)
- CCTG 7.8M
- CASI 25.4K
- Earning Date
- CCTG 12-26-2025
- CASI 11-14-2025
- Dividend Yield
- CCTG N/A
- CASI N/A
- EPS Growth
- CCTG N/A
- CASI N/A
- EPS
- CCTG N/A
- CASI N/A
- Revenue
- CCTG $17,631,489.00
- CASI $26,846,000.00
- Revenue This Year
- CCTG N/A
- CASI N/A
- Revenue Next Year
- CCTG N/A
- CASI N/A
- P/E Ratio
- CCTG N/A
- CASI N/A
- Revenue Growth
- CCTG 19.55
- CASI 21.72
- 52 Week Low
- CCTG $0.16
- CASI $1.09
- 52 Week High
- CCTG $2.61
- CASI $5.32
- Technical
- Relative Strength Index (RSI)
- CCTG 29.21
- CASI 36.04
- Support Level
- CCTG $0.16
- CASI $1.15
- Resistance Level
- CCTG $0.42
- CASI $1.48
- Average True Range (ATR)
- CCTG 0.23
- CASI 0.11
- MACD
- CCTG -0.02
- CASI -0.00
- Stochastic Oscillator
- CCTG 4.34
- CASI 27.78
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.